News

Formal statement on the forthcoming US Brainstorm trial

US Brainstorm Trial Statement

26/Feb/2013

We have had many inquires regarding the BrainStorm Stem Cell Therapeutics Clinical Trial.  BrainStorm is currently conducting a Phase IIa dose-escalating trial at the Hadassah Medical Center in Israel. We are working with Brainstorm on a planned Phase II study in the US. We hope to begin the trial in the second half of 2013. We will continue to follow the progress of the study in Israel and will keep our website and the NEALS website (www.alsconsortium.org) current on all new trials and start dates. Thank you for your interest.

patient

U.S. News and World Report Best Hospitals 2012-2013

U.S. News & World Report ranks Mass General the #1 hospital in America based on our quality of care, patient safety and reputation in 16 different specialties. Learn more about why we're #1.

Search the Mass General news archive

Search the archive for previously published news articles, press releases and publications.

View all departments

Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.

  • © 2013 Massachusetts General Hospital
  • 617-726-2000
  • TDD: 617-724-8800

Site Map

  • Partners Healthcare
  • Harvard Medical School
  • Massachusetts General Physicians Organization
  • MassGeneral Hospital for Children
  • Individual Care, Global Impact: The Campaign for the Third Century of MGH Medicine
  • Proto